43rd Annual J.P. Morgan Healthcare Conference Bora Pharmaceuticals has been
Bora Biologics Announces Strategic Collaboration to Accelerate Key CMC Development
Bora Pharmaceuticals Announces Unveiling of New Multi-Purpose Small Molecule Site
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Appoints J.D. Mowery As First Division President Of Its
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Tanvex BioPharma, Inc. (“Tanvex” or “the Company”, TWSE: 6541), the
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
